Skip to main content
. 2017 May 15;35(9):1758–1767. doi: 10.1097/HJH.0000000000001412

FIGURE 4.

FIGURE 4

. Plasma renin activity (a) and plasma aldosterone (b) levels (b1) and baseline–endpoint change (b2) following 8 weeks of treatment with placebo, valsartan, nebivolol, or the single-pill combination. Neb, nebivolol; PRA, plasma renin activity; SPC, single-pill combination; Val, valsartan. Modified with permission from [80]. P < 0.05; ∗∗∗ P < 0.001.